Results 171 to 180 of about 36,304 (249)

Increased autoantibodies against incretin indicate poor prognosis in patients with diabetes. [PDF]

Sci Rep
Takemoto M, Zhang BS, Hayashi A, Yamagata H, Yoshida Y, Koshizaka M, Onishi S, Yamaga M, Yoshida T, Hashimoto T, Ohtake N, Ishikawa T, Takizawa H, Hiwasa T.   +13 more
europepmc   +1 more source

Incretin-based therapies for obesity and disordered eating: optimising care in general practice. [PDF]

Fam Med Community Health
Atlantis E, Wu R, Dixon J.
europepmc   +1 more source

GLP-1 and GIP Beyond Glycaemia: Evolutionary Roles in Energy Optimisation and Organ Protection. [PDF]

Diabetes Metab Res Rev
Tuccinardi D, Watanabe M, Masi D, Gianfrilli D, Manfrini S, le Roux CW.   +5 more
europepmc   +1 more source

Identification of lactic acid bacteria strains modulating incretin hormone secretion and gene expression in enteroendocrine cells [PDF]

, 2016
Calderwood, Danielle, Gillespie, Anna L., Graham, Stewart F., Grant, Irene R., Green, Brian D., Grover, Sunita, Panwar, Harsh, Wylie, Alistair R.   +7 more
core   +1 more source

Hypothalamisches Incretin [PDF]

, 2019
openaire   +1 more source

The Risk of Immune‐Mediated Skin Disease Under Dipeptidyl‐Peptidase IV Inhibitor: A Global Population‐Based Study

International Journal of Dermatology, Volume 65, Issue 2, Page 356-358, February 2026.
Noor Mruwat, Noga Givon‐Lavi, Ralf J. Ludwig, Khalaf Kridin   +3 more
wiley   +1 more source

Incretin-based therapies for cardio-kidney-liver-metabolic disease: the role of the liver in the modern era of chronic disease management. [PDF]

Clin Mol Hepatol
Elangovan H, Loomba R, Muthiah M, Schattenberg J, Zheng MH, Noureddin M, Mantzoros C, George J.   +7 more
europepmc   +1 more source

The Influence of Glucagon-like Peptide-1 Receptor Agonists and Other Incretin Hormone Agonists on Body Composition. [PDF]

Int J Mol Sci
Chrysavgis L, Mourelatou NG, Koloutsou ME, Rozani S, Cholongitas E.   +4 more
europepmc   +1 more source

Incretin-Based Therapies Through the Decades: Molecular Innovations and Clinical Impact. [PDF]

Med Sci (Basel)
Lee AA, Khotina VA, Kashirskikh DA, Voronko OE, Gasanov VAO, Vasiliev AV.   +5 more
europepmc   +1 more source

JNK3 regulates β cell responses to incretins in human islets and mouse models. [PDF]

J Clin Invest
Louzada RA, Gonzalez Medina M, Pita-Grisanti V, Bouviere J, Neves AF, Almaça J, Han MS, Davis RJ, Leibowitz G, Blandino-Rosano M, Bernal-Mizrachi E.   +10 more
europepmc   +1 more source